Avenacy launches Tranexamic Acid Injection, USP in the U.S. market.
24 Jun 2024 //
BUSINESSWIRE
Rubicon`s Generic Tranexamic Acid Receives Approval in US
11 Jun 2024 //
FDA
Nexus` Generic Tranexamic Acid Receives Approval in the U.S.
16 Apr 2024 //
FDA
Gland Pharma`s Generic Tranexamic Acid Receives Approval in the U.S
16 Apr 2024 //
FDA
Enforcement Report - Week of October 12, 2022
12 Oct 2022 //
FDA
Hyloris Reports Positive Phase 1 Data for HY-004
20 Jul 2022 //
GLOBENEWSWIRE
Amring Pharmaceuticals Inc. Licenses LYSTEDA to Pierre Fabre for Mexican Market
29 Sep 2021 //
BUSINESSWIRE
Received CEP approval for Tranexamic Acid
18 Aug 2021 //
PRESS RELEASE
Tranexamic Acid Mouthwash Failure update: Presented at ISTH
23 Jul 2021 //
PIOS
FDA: Risk of Inadvertent Intrathecal Administration of Tranexamic Acid Injection
04 Dec 2020 //
BUSINESSWIRE
TA During Prehospital Transport in Patients at Risk for Hemorrhage After Injury
06 Oct 2020 //
JAMA NETWORK
Enforcement Report - Week of September 9, 2020
09 Sep 2020 //
FDA
Mylan Initiates Voluntary Nationwide Recall of Four Lots of Amiodarone HCl INJ
28 Aug 2020 //
PRNEWSWIRE
Apotex`s Generic Tranexamic acid Receive Approval in U.S
15 Jan 2020 //
FDA
Strides Bengaluru unit gets `Voluntary Indicated Action` status from USFDA
22 Jul 2019 //
BUSINESS STANDARD
Caplin`s Generic Tranexamic Acid Receives Approval in US
20 Jul 2019 //
FDA
DCGI directs state DCs to ask manufacturers of 7 drugs, identified ADRs drugs
12 Apr 2019 //
PHARMABIZ
ERFA Canada 2012 Recalls Erfa-Tranexamic 100 mg/mL (5 ml)
08 May 2018 //
HEALTH CANADA
Akorn’s Generic Tranexamic Acid Receives Approval In US
29 Sep 2017 //
FDA
Zydus Pharm’s Generic Tranexamic Acid Receives Approval In US
19 Jul 2017 //
FDA
Micro Lab’s Generic Tranexamic Acid Receives Approval In US
29 Jun 2017 //
FDA
Amneal Pharms Generic Tranexamic Acid Receives Approval In US
28 Feb 2017 //
FDA
Gland Pharma Ltd`s Generic Tranexamic Acid Receives Approval In US
13 Feb 2017 //
FDA
Aurobindo Pharma gets USFDA nod for two generic drugs
18 Jan 2016 //
ECONOMIC TIMES